Zobrazeno 1 - 10
of 26
pro vyhledávání: '"YunZhen He"'
Autor:
Jian Ming, Yunzhen He, Yi Yang, Min Hu, Xinran Zhao, Jun Liu, Yang Xie, Yan Wei, Yingyao Chen
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 20, Iss 1, Pp 1-9 (2022)
Abstract Background Health Technology Assessment (HTA) has been widely recognized as informing healthcare decision-making, and interest in HTA of medical devices has been steadily increasing. How does the assessment of medical devices differ from tha
Externí odkaz:
https://doaj.org/article/9eef2bcb30f44110b1531bc8713c7232
Publikováno v:
BMJ Open, Vol 12, Iss 11 (2022)
Objective Diabetes mellitus is a common condition often associated with an ageing population. However, only few longitudinal studies in China have investigated the incidence of diabetes and identified its risk factors. Therefore, this study aimed to
Externí odkaz:
https://doaj.org/article/59acf5ec9023485597b96d529a0fb35c
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Population-based screening was essential for glaucoma management. Although various studies have investigated the cost-effectiveness of glaucoma screening, policymakers facing with uncontrollably growing total health expenses were
Externí odkaz:
https://doaj.org/article/73267bc1a3b34aa18fd06f37de7bb230
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0278026 (2022)
BackgroundThe prevention and control of hypertension should be an effective way to reduce deaths and it has been a high priority in China. In 2013, the Chinese government increased the subsidy standard for the National Essential Public Health Service
Externí odkaz:
https://doaj.org/article/732c8e6b0db643a2803c3513e259e25d
Autor:
Yunzhen He, Guanshen Dou, Qiaoyun Huang, Xinyu Zhang, Yingfeng Ye, Mengcen Qian, Xiaohua Ying
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0190320 (2018)
Healthcare system reform of Sanming city has become a leading healthcare reform model in China. It has developed a rigorous pharmaceutical reform consisted of the Zero Mark-up Drug Policy and the Centralized Procurement of Medicine Policy to bring do
Externí odkaz:
https://doaj.org/article/4c03b3cc0be7478292c99b36714adceb
Publikováno v:
Automation in Construction. 146:104659
Autor:
Huilin Sheng, Weihua Dong, YunZhen He, Mengyun Sui, Hongzheng Li, Ziyan Liu, Huiying Wang, Zhi Chen, Long Xue
Publikováno v:
Medicine. 101:e32395
Hypertension is a prevalent and costly health condition in China. Little is known about variation of the inpatient and outpatient expenditures attributable to hypertension between prefecture-level administrative regions (PARs) and the drivers of such
Publikováno v:
BMJ Open. 12:e060730
ObjectiveDiabetes mellitus is a common condition often associated with an ageing population. However, only few longitudinal studies in China have investigated the incidence of diabetes and identified its risk factors. Therefore, this study aimed to i
Background: The prevention and control of hypertension should be an effective way to reduce deaths and it has been a high priority in China. The Chinese government issued the National Essential Public Health Services Package (NEPHSP) in 2009; this in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a7a52e359bf9fca43b611f356e34baa
https://doi.org/10.21203/rs.3.rs-777711/v1
https://doi.org/10.21203/rs.3.rs-777711/v1